The 21st century has seen significant progress in GLP-1R agonist research, with liraglutide (exenatide) becoming the first GLP-1R agonist to be approved by the US Food and Drug Administration (FDA) for the treatment of T2DM in 2005 (Jensterle et al., 2022)
Its essential to follow the manufacturer's instructions and consider starting with a lower dose to assess your body's response
This study by Nicolau et al
[DOI] [Google Scholar] 81.Liebel S.W., Johnson P.K., Lindsey H.M., Russell H.A., Hovenden E.S., Velez C., Tate D.F
You will also want to take CoQ10 if you are on any statins or beta-blockers, because they block the production of CoQ10
6c, d), indicating GLP-1R may regulate the ECM metabolic activity in chondrocyte